I’m excited to share with you my passion for our department and our commitment to excellence in urologic care. University of Florida Department of Urology has earned the reputation as one of the leading urology programs in the United States. In keeping with UF Health’s mission, we remain committed to providing outstanding patient care, conducting innovative research and training tomorrow’s leaders.
This website was created with the sole purpose of providing patients as well as referring physicians a comprehensive educational resource through descriptions of our diverse clinical offerings for a wide range of urologic diseases and conditions. In addition, this site provides details about our ongoing innovative research, alumni association (UroGators), current events as well as educational programs.
I hope you find this website helpful and invite you to learn more about the exceptional services provided by the University of Florida Department of Urology.
Li-Ming Su, MD, FRCS(Glasg)
Secretary General, Endourological Society
Pete and Carolyn Newsome Professor of Urologic Oncology
Chair, Department of Urology
Department of Urology
The Department of Urology faculty is comprised of outstanding clinicians and surgeons who have all received advanced fellowship training, covering a wide range of urologic subspecialization in efforts to provide the most up to date treatments for our patient population. I am proud to serve next to such thoughtful, experienced, compassionate and credible individuals who are all committed to providing each patient with attentive and personalized care.
UF Urology provides the best in urologic patient care to more than 20,000 patients each year. We subscribe to and provide a multidisciplinary approach to some of the most challenging urologic disorders by combining the expertise of physicians from many specialties within UF Health, all with the common goal of providing the best patient-centered care. Often these visits can be coordinated to allow for comprehensive review of a patient’s urologic condition all in one visit to UF Health. We also provide a wide array of nonsurgical as well as surgical treatments ranging from active surveillance, percutaneous, endoscopic, laparoscopic, robotic and open surgery. We also incorporate the latest imaging technologies for both diagnostic and therapeutic purposes such as multiparametric prostate magnetic resonance imaging (MRI), positron emission tomography (PET) scan, multi-phase computed tomography (CT) scan, as well as nuclear renal and bone scan.
UF Urology is committed to training world-class clinicians and academic urologists through its medical student, residency and advanced fellowship training programs. Our educational programs have garnered national recognition for providing a superior education and training experience in a comprehensive array of subspecialty areas. Not only are our trainees exposed to academic urology, we also provide a unique exposure to a private urologic practice as well as practice in a Veterans Affairs hospital setting. Two-thirds of our residency graduates have gone on to complete advanced fellowship training in subspecialties such as urologic oncology, female urology, male infertility, reconstructive urology and pediatric urology at world renowned urologic centers throughout the United States.
The Department of Urology has a history of receiving substantial NIH and federal funding. We also hold a NIDDK sponsored T32 training research grant in benign urologic diseases to help develop research fellows in the skills required for a successful academic career in urologic research. Our researchers and clinicians pursue innovative advances in basic, clinical, and translational research, with the ultimate goal of improving patient care. Some of our specific research includes studying the immune system response to renal stone formation, modeling the effect of gastric bypass surgery on kidney stone disease in animal models, investigating oxalate metabolism, identifying risk factors for uric acid stone formation, immunotherapy and immune system escape by urologic cancers, clinical trials for advanced bladder and kidney cancer, multiparametric MRI targeting of prostate cancer and differentiating kidney tumor subtype using novel optical imaging technologies.